NEW YORK ( TheStreet) -- Jazz Pharmaceuticals (Nasdaq: JAZZ) hit a new 52-week high Friday as it is currently trading at $40.13, above its previous 52-week high of $39.08 with 561,061 shares traded as of 10:26 a.m. ET. Average volume has been 735,000 shares over the past 30 days. Jazz has a market cap of $1.4 billion and is part of the health care sector and drugs industry. Shares are up 79.2% year to date as of the close of trading on Thursday. Jazz Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes products for neurology and psychiatry primarily in the United States. The company has a P/E ratio of 27.8, below the average drugs industry P/E ratio of 28.7 and above the S&P 500 P/E ratio of 17.7.
- Practice your JAZZ trading strategies and win cash in our stock game.